Louisiana State Employees Retirement System Takes $2.01 Million Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Louisiana State Employees Retirement System acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 25,900 shares of the company’s stock, valued at approximately $2,014,000.

Several other institutional investors have also added to or reduced their stakes in ACHC. Headlands Technologies LLC acquired a new position in Acadia Healthcare during the third quarter valued at approximately $25,000. Point72 Hong Kong Ltd acquired a new position in Acadia Healthcare during the first quarter valued at approximately $38,000. Fifth Third Bancorp raised its position in Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after purchasing an additional 136 shares in the last quarter. Belpointe Asset Management LLC raised its position in Acadia Healthcare by 75.7% during the first quarter. Belpointe Asset Management LLC now owns 982 shares of the company’s stock valued at $71,000 after purchasing an additional 423 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in Acadia Healthcare during the third quarter valued at approximately $96,000.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock opened at $70.25 on Thursday. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare Company, Inc. has a twelve month low of $66.49 and a twelve month high of $87.77. The stock has a market cap of $6.49 billion, a price-to-earnings ratio of -280.99, a P/E/G ratio of 2.16 and a beta of 1.31. The company’s fifty day moving average is $79.62 and its 200 day moving average is $77.60.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. The business had revenue of $742.80 million for the quarter, compared to analysts’ expectations of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.70 earnings per share. Sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current year.

Analysts Set New Price Targets

ACHC has been the subject of several research analyst reports. UBS Group boosted their price objective on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, March 5th. TD Cowen boosted their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. Mizuho boosted their target price on shares of Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a research note on Wednesday, March 6th. Finally, Stephens raised shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price on the stock in a research note on Friday, January 5th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $91.22.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 2.80% of the company’s stock.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.